Harrow Health, Inc. (HROW)
NASDAQ·Healthcare·Drug Manufacturers - Specialty & Generic
$40.45
-2.32%
Mkt Cap $1.44B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 2, 2026 | $90.00M | $89.09M | -1.00% | $0.40 | $0.26 | -35.00% | — | — |
| Q4 2025 Nov 10, 2025 | $88.03M | $71.64M | -18.62% | $0.22 | $0.33 | +50.00% | — | — |
| Q3 2025 Aug 11, 2025 | $73.95M | $63.74M | -13.80% | $0.31 | $0.24 | -23.40% | — | — |
| Q2 2025 May 8, 2025 | $67.88M | $47.83M | -29.53% | $0.02 | -$0.38 | -2000.00% | — | — |
| Q1 2025 Mar 27, 2025 | $58.41M | $66.83M | +14.42% | $0.11 | $0.25 | +127.27% | — | — |
| Q4 2024 Nov 13, 2024 | $59.09M | $49.26M | -16.64% | -$0.05 | -$0.12 | -140.00% | — | — |
| Q3 2024 Aug 7, 2024 | $49.06M | $48.94M | -0.25% | -$0.25 | -$0.13 | +48.00% | — | — |
| Q2 2024 May 13, 2024 | $37.27M | $34.59M | -7.20% | -$0.25 | -$0.28 | -12.00% | — | — |
| Q1 2024 Mar 19, 2024 | $37.86M | $36.35M | -3.98% | -$0.05 | -$0.27 | -455.56% | — | — |
| Q4 2023 Nov 13, 2023 | $37.86M | $34.27M | -9.50% | -$0.02 | -$0.09 | -467.82% | — | — |
| Q3 2023 Aug 9, 2023 | $38.01M | $33.47M | -11.94% | -$0.01 | -$0.02 | -250.26% | — | — |
| Q2 2023 May 11, 2023 | $25.15M | $26.10M | +3.79% | -$0.06 | -$0.03 | +50.00% | — | — |
| Q1 2023 Mar 23, 2023 | $21.40M | $20.33M | -5.00% | -$0.15 | $0.07 | +146.67% | — | — |
| Q4 2022 Nov 14, 2022 | $23.14M | $22.82M | -1.39% | -$0.00 | -$0.06 | -9577.42% | — | — |
| Q3 2022 Aug 9, 2022 | $22.07M | $23.32M | +5.66% | -$0.00 | $0.01 | +3325.81% | — | — |
| Q2 2022 May 5, 2022 | $19.48M | $22.12M | +13.53% | $0.01 | $0.03 | +185.71% | — | — |
| Q1 2022 Mar 10, 2022 | $19.35M | $20.19M | +4.34% | $0.08 | -$0.01 | -112.50% | — | — |
| Q4 2021 Nov 9, 2021 | $15.44M | $18.71M | +21.21% | -$0.00 | $0.05 | +1139.50% | — | — |
| Q3 2021 Aug 10, 2021 | $15.71M | $18.13M | +15.43% | -$0.13 | -$0.11 | +15.38% | — | — |
| Q2 2021 May 11, 2021 | $13.66M | $15.44M | +13.05% | $0.00 | $0.01 | +128.31% | — | — |